Recruiting Myelofibrosis Studies in Sofia
A Study of Selinexor Monotherapy in Subjects with JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
The main purpose of this study with corresponding optional expansion is to evaluate the efficacy of selinexor in JAKi-naïve participants with myelofibrosis (MF) and moderate thrombocytopenia based on ...
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
This study evaluates either KRT-232 or TL-895 in treatment naïve patients with myelofibrosis (MF) The study will be conducted in 2 stages. Stage 1 will evaluate safety, tolerability, and efficacy of ...
About Myelofibrosis Clinical Trials in Sofia
Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.
There are currently 2 myelofibrosis clinical trials recruiting participants in Sofia, . These studies are seeking a combined 170 participants. Research is being sponsored by Karyopharm Therapeutics Inc, Kartos Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelofibrosis Clinical Trials in Sofia — FAQ
Are there myelofibrosis clinical trials in Sofia?
Yes, there are 2 myelofibrosis clinical trials currently recruiting in Sofia, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Sofia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sofia research site will contact you about next steps.
Are clinical trials in Sofia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sofia studies also compensate for your time and travel.
What myelofibrosis treatments are being tested?
The 2 active trials in Sofia are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov